RDNT
RadNet, Inc.
Next earnings Aug 6, 2026 · consensus $0.21 EPS, $621M rev
Last earnings -3.9% on 2026-05-11
$60.01
▲ +3.18%$60.01▲ +8.65%
over 1Y
L $51.87EODHDH $84.48
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.2%
1W+11.7%
1M+10.9%
3M+1.0%
YTD-15.4%
1Y+8.7%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 14 analysts
Buy
Imaging volume and AI story are real, but FY2025 flipped to a net loss while leverage and share count keep creeping — own it, don't chase.
RadNet is executing on the top line — FY2025 revenue grew 11.5% to $2.04B, the fifth straight year of growth, with center count expanding from 366 in 2023 to 418 in 2025 and commercial insurance revenue (the highest-margin payor mix) up to $1.13B from $1.02B. The MD&A frames a credible two-segment story: a scaling Imaging Centers business plus a Digital Health segment housing 22 FDA-cleared AI solutions, 2,000+ external customers, and three recently closed acquisitions (iCAD, See-Mode, CIMAR). Operating cash flow of $299M (+28.2% YoY) confirms the core business throws off real cash, and the $767M cash balance gives ample runway.
Sources: SEC EDGAR (CIK 0000790526, latest 10-Q filed 2026-05-11) · EODHD · analysis by claude-code · as of 6/25/2026, 12:48:13 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.